Your browser doesn't support javascript.
loading
Differences between residual and primary choledocholithiasis in cholecystectomy patients.
Ruiz Pardo, José; García Marín, Andrés; Ruescas García, Francisco Javier; Jurado Román, Miguel; Scortechini, Marcelo; Sagredo Rupérez, María Pilar; Valiente Carrillo, Juan.
Afiliação
  • Ruiz Pardo J; Cirugía General y del Aparato Digestivo, Hospital de Hellín, España.
  • García Marín A; Cirugía General y del Aparato Digestivo, Hospital de Hellín, España.
  • Ruescas García FJ; Cirugía General y del Aparato Digestivo, Hospital de Hellín, España.
  • Jurado Román M; Cirugía General y del Aparato Digestivo, Hospital de Hellín, España.
  • Scortechini M; Cirugía General y del Aparato Digestivo, Hospital de Hellín, España.
  • Sagredo Rupérez MP; Cirugía General y del Aparato Digestivo, Hospital de Hellín, España.
  • Valiente Carrillo J; Cirugía General y del Aparato Digestivo, Hospital de Hellín, España.
Rev Esp Enferm Dig ; 112(8): 615-619, 2020 Aug.
Article em En | MEDLINE | ID: mdl-32496117
ABSTRACT

INTRODUCTION:

choledocholithiasis can be primary from stones originally formed in the choledocho or secondary from stones that have migrated from the gallbladder to the choledocho. The objective of this study was to determine the clinical differences between both types of choledocholithiasis in cholecystectomy patients. MATERIAL AND

METHODS:

a comparative and retrospective study was performed of cholecystectomy patients who presented choledocholithiasis. Residual or secondary choledocholithiasis (group 1) was defined as those which appear in the first two years after cholecystectomy and primary choledocholithiasis (group 2) was defined as those which appear two years after cholecystectomy. Choledocholithiasis was confirmed by endoscopic retrograde cholangiopancreatography (ERCP) or surgery.

RESULTS:

patients with primary choledocholithiasis (n = 14) were older (61.5 ± 20.3 vs 74.4 ± 10.5 years; p = 0.049) and had a greater body mass index (BMI) (27.7 ± 4.3 vs 31.6 ± 4.6 kg/m2; p = 0.043) and a larger extrahepatic bile duct diameter (10.7 ± 2.7 vs 14.7 ± 3.5 mm; p = 0.004) compared to patients with residual or secondary choledocholithiasis (n = 11). All patients were treated by ERCP. There were no differences between groups 1 and 2 regarding recurrences (36.2 % vs 14.3 %; p = 0.350), disease-free survival (64.6 ± 30.9 vs 52.2 ± 37.7 months; p = 0.386) and overall survival (73.6 ± 32.4 vs 54 ± 41.9 months; p = 0.084).

CONCLUSIONS:

patients with primary choledocholithiasis were older and had a greater BMI and a larger diameter of the bile duct compared to patients with residual or secondary choledocholithiasis. ERCP is a good therapeutic option for the resolution of both types of choledocholithiasis.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colecistectomia Laparoscópica / Coledocolitíase Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Rev Esp Enferm Dig Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colecistectomia Laparoscópica / Coledocolitíase Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Rev Esp Enferm Dig Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2020 Tipo de documento: Article